A randomised double blind study looking at combination granisetron and cyclizine anti-emetic therapy versus single use granisetron or cyclizine in day case gynaecological patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN75581229

Enrollment

960

Registered

2003-09-12

Start date

2002-06-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery: Gynaecological Surgery Gynaecological

Interventions

Combination granisetron and cyclizine anti-emetic therapy versus single use granisetron or cyclizine

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Patients over 18 years of age undergoing a day case gynaecological procedure.

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

Measure	Time frame
To see if the combination anti-emetic regime reduces post-operative nausea and vomiting.	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026